Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Barinthus Biotherapeutics (BRNS) Exchange Rate Effect (2020 - 2025)

Barinthus Biotherapeutics (BRNS) has disclosed Exchange Rate Effect for 6 consecutive years, with -$1.8 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Exchange Rate Effect fell 129.72% year-over-year to -$1.8 million, compared with a TTM value of -$752000.0 through Sep 2025, down 111.66%, and an annual FY2024 reading of -$2.0 million, down 193.09% over the prior year.
  • Exchange Rate Effect was -$1.8 million for Q3 2025 at Barinthus Biotherapeutics, down from $5.3 million in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $6.2 million in Q3 2024 and bottomed at -$7.3 million in Q4 2024.
  • Average Exchange Rate Effect over 5 years is $24894.7, with a median of $205000.0 recorded in 2021.
  • The sharpest move saw Exchange Rate Effect plummeted 2235.74% in 2021, then skyrocketed 1604.17% in 2022.
  • Year by year, Exchange Rate Effect stood at $336000.0 in 2021, then surged by 1604.17% to $5.7 million in 2022, then tumbled by 80.41% to $1.1 million in 2023, then crashed by 754.81% to -$7.3 million in 2024, then surged by 75.02% to -$1.8 million in 2025.
  • Business Quant data shows Exchange Rate Effect for BRNS at -$1.8 million in Q3 2025, $5.3 million in Q2 2025, and $3.1 million in Q1 2025.